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Abstract
Objective—To evaluate the impact of a short luteal phase on fecundability.
Design—Prospective, time to pregnancy cohort study
Setting—Community-based cohort
Patient(s)—Women trying to conceive, ages 30–44 years, without known infertility
Intervention(s)—Daily diaries, ovulation prediction testing, standardized pregnancy testing
Main Outcome Measure(s)—Subsequent cycle fecundability
Result(s)—1,635 cycles from 284 women were included in the analysis. A short luteal phase 
(length of 11 days or less including the day of ovulation) occurred in 18% of observed cycles. 
Mean luteal phase length was 14 days. Significantly more women with a short luteal phase were 
smokers. After adjustment for age, women with a short luteal phase had 0.82 times the odds of 
pregnancy (95% CI: 0.46–1.47) in the subsequent cycle immediately following the short luteal 
phase when compared to women without a short luteal phase. Women with a short luteal length in 
the first observed cycle had significantly lower fertility after the first 6 months of pregnancy 
attempt, but at 12 months, there was no significant difference in cumulative probability of 
pregnancy.
Conclusion(s)—Although an isolated cycle with a short luteal phase may negatively impact 
short-term fertility, incidence of infertility at 12 months was not significantly higher among these 
women.
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A short luteal phase length may have negative impact on natural fertility.
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Introduction
The luteal phase occurs after ovulation and corresponds to the time when a functioning 
corpus luteum secretes progesterone (1, 2). Menses is a response to the late luteal phase drop 
in progesterone after failure of the corpus luteum if pregnancy is not achieved (3–5). Luteal 
phase deficiency (LPD) is a condition secondary to insufficient progesterone exposure and 
failure to maintain the normal secretory endometrium required for embryo implantation (6). 
LPD may be due to lack of adequate progesterone secretion from the corpus luteum or an 
inappropriate endometrial response to a normal progesterone level (7, 8). A shortened luteal 
phase is often considered to be a clinical manifestation of LPD (1, 9–11).
Despite the essential role of progesterone in establishing the appropriate endometrial 
environment necessary for conception, LPD has not clearly been linked with delayed time to 
pregnancy or infertility (2, 12, 13). A luteal phase defect results in dysfunctional endometrial 
development during the narrow interval when an embryo is present in the uterine cavity and 
capable of implantation (6, 8, 10, 14). Thus, women with clinical signs of a LPD, such as a 
shortened luteal phase, may have an impairment of implantation or maintenance of 
pregnancy (10, 12, 14, 15).
Diagnosing LPD in a clinical setting has proven difficult. A luteal phase biopsy showing a 
lag in endometrial development was previously considered the gold standard diagnostic test 
(16). However, prospective randomized studies have shown that histologic evaluation of the 
luteal endometrium is poorly correlated with fertility (17, 18). Thus, luteal phase biopsy is 
not currently recommended as part of an evaluation of infertility (6). Although there is no 
standard approach to diagnosing a LPD, this does not mean that such a condition does not 
exist nor does it mean that proper luteal phase function is not important to conception.
Because the corpus luteum persists in an ongoing pregnancy, the luteal phase does not “end” 
in conception cycles. This makes evaluating the direct impact of a shortened luteal phase 
difficult. The association between a shortened luteal phase and natural fertility has not been 
previously evaluated. We hypothesized that a short luteal phase would impair a woman’s 
fertility. We sought to determine the impact of a short luteal phase on fecundability, the 
probability of conceiving in a given cycle.
Material and Methods
This is a sub-study within Time to Conceive (TTC), an ongoing time-to-pregnancy study 
approved by the Institutional Review Board of the University of North Carolina. English-
speaking women between 30 and 44 years of age, who were attempting to conceive for 3 
months or less, were eligible for participation in the study. This analysis includes women 
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recruited between April 2008 and December 2015. Women were recruited by direct 
advertising, online, and on-air marketing strategies. Women with a history of infertility, 
polycystic ovarian disease, pelvic inflammatory disease, endometriosis, pelvic radiation, or 
with a partner with a history of infertility were excluded from participation. After informed 
consent was obtained, women completed a baseline questionnaire, which included survey of 
demographics, height, weight, and medical history for both the participant and her partner 
and of behaviors such as tobacco, alcohol, and caffeine use. The baseline questionnaire also 
queried duration of pregnancy attempt by asking specific questions regarding prior birth 
control methods: type, duration of use in the past year, and date of cessation; date participant 
started having intercourse without preventing pregnancy; and number of menstrual cycles at 
risk for pregnancy.
While attempting to conceive, women recorded information in a daily diary and were 
followed without intervention until pregnancy was detected. The daily diary included 
information on vaginal bleeding, markers of ovulation (cervical mucus scores, basal body 
temperature, and ovulation predictor kit (OPK) results), acts of intercourse, and pregnancy 
test results. Women provided daily data for up to four months if no positive pregnancy test 
occurred. If women were not pregnant after the fourth month, a monthly diary was 
completed for the remainder of the study, up to 12 months, or until pregnancy was achieved. 
A subset of women were provided free digital OPK tests and provided standardized testing 
instructions. However, use of this method of ovulation prediction was not a requirement for 
study participation and women could use any brand of OPK test they preferred. All women 
were provided home pregnancy tests (with a sensitivity of 20 mIU human chorionic 
gonadotropin (hCG) per mL) and standardized pregnancy testing instructions. Women were 
instructed to test for pregnancy on days 28, 31, and 34 of their cycles if they did not have 
menstrual bleeding. Women who conceived in the first cycle were excluded from this 
evaluation.
Menses was defined as 3 or more days of bleeding or spotting (with at least one day of 
bleeding), followed by 2 consecutive days without bleeding or spotting. The first day of a 
cycle was defined as the first day of bleeding occurring during menses. Ovulation was 
estimated to have occurred on the day after a positive OPK test result. Luteal phase length 
was determined as starting on the day of ovulation (day after a positive OPK test) and 
ending on the last day prior to menses. This is the equivalent to subtracting the date of the 
day after positive OPK from the date of menses start. A short luteal phase was defined as 11 
or fewer days. In sensitivity analysis, fecundability was also evaluated with a luteal phase of 
10 days or less. Cycles which had a luteal phase length of <5 or >20 days were excluded 
from the analysis in an attempt to exclude anovulatory cycles and occult pregnancies. 
Pregnancy was defined as a positive home pregnancy test.
Covariates were categorized to aid in interpretation. Maternal age was modeled with 3 
categories: <35 years, 35–37 years and >37 years. Education level was categorized into 4 
groups: less than a college degree, college graduate, some graduate level work, and graduate/
professional degree. Body mass index (BMI) was categorized into 4 groups: underweight 
(<18.5 kg/m2), normal (≥18.5 and <25 kg/m2), overweight (≥25 and <30 kg/m2), and obese 
(≥30 kg/m2).
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Bivariate analyses were conducted to compare women based on their luteal length in their 
first observed cycle. Fisher’s exact test and the Kruskal-Wallis test were used to evaluate 
relationships between potential covariates and luteal length for categorical and continuous 
variables, respectively. Subsequently, discrete-time Cox proportional hazards models with 
time-varying (cycle-specific) exposure variables were created to determine the impact of 
luteal length on probability of pregnancy in the next cycle (subsequent cycle fecundability). 
As a cycle with an outcome of pregnancy does not have a defined luteal length, only 
fecundability in a future cycle can be evaluated; thus the luteal length of the immediately 
preceding cycle was considered as a predictor for the event of pregnancy in the Cox 
proportional hazards models. To adjust for potential confounders, covariates were included 
in models. The full model was reduced to include only covariates strongly predictive of 
pregnancy in our cohort or in prior studies - our final model included the covariates age and 
smoking. These models account for both right censoring and left truncation (due to women 
enrolling in cycles 1, 2, 3 or 4 of their pregnancy attempt), which were present in the data; a 
fecundability ratio (FR) of less than 1.0 suggests reduced fecundability.
As a secondary analysis, adjusted Kaplan-Meier curves were also created using the luteal 
length in the first study cycle as the exposure, assuming the woman did not conceive in the 
first study cycle, as luteal phase length can not be defined in a conception cycle. The null 
hypothesis that there was no difference in overall fertility by 6 and 12 months among women 
in which the first cycle luteal length was no more than 11 days compared to women in which 
the first cycle luteal length was more than 11 days was tested using the log-rank test.
Sensitivity analyses were performed in order to further evaluate the relationship between 
luteal length and fecundability. First, the luteal length exposure variable was modified to be 
more stringent, with a short luteal phase being one that was 10 days or less in length and FR 
determined using the model above. Second, the luteal length exposure value was categorized 
into short (5–11 days), normal (12–15 days) and long (16–20 days) and FRs were 
determined using the model as above, with the normal category as the reference group.
In an attempt to explore the impact of recurrent cycles with a short luteal phase, we 
evaluated women who provided at least 3 study cycles. In this investigation, women who 
failed to conceive in the first 2 study cycles were evaluated for pregnancy in the subsequent 
cycle. Women were grouped according to 1) no cycles with a short luteal length, 2) one 
cycle with a short luteal length, 3) both observed cycles with a short luteal length. Due to the 
limited number of women in this evaluation, only descriptive statistics are provided.
Results
The TTC cohort included observations from 933 women. Thirty-two percent of women 
(296) in the cohort reported at least one cycle with a positive OPK. Out of 3,999 total cycles 
in the TTC data, 598 had luteal length determined through the use of a positive OPK test 
(15%). Of those women who had at least one cycle with luteal length determined through the 
use of a positive OPK test, 149 had at least one case where two consecutive cycles had luteal 
length determined through the use of a positive OPK test (50%). Figure 1 represents the 
selection for inclusion in this sub-study. A total of 1,635 cycles from 284 women were 
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included in this analysis, excluding women who conceived in the first cycle of attempt 
(fecundability in the first study cycle was 18%). Fifty-nine percent of women included in the 
analysis become pregnant (159 women). Although the study enrolled women between 30 
and 45 years of age, 68% of the participants were less than 35 years of age, 20% between 35 
and 37 years of age, and 12% 38 years or older. The majority of patients were Caucasian 
(77%) and highly educated (65% with a graduate degree). The majority of women had a 
normal BMI (63%), while 4% were underweight and 33% were overweight or obese.
In the first observed cycle, 18% of women had a short luteal phase (11 or fewer days). Most 
observed cycles did not have a short luteal phase, as a short luteal phase was present in 18% 
of all observed cycles. Mean luteal phase length in our cohort was 14 days (Figure 2). 
Women with a short luteal phase were more likely to be smokers than those who did not 
have a short luteal phase (6% versus 1%, respectively). No other significant differences in 
baseline characteristics were observed between women who had a short luteal phase and 
those who did not (Table 1).
A total of 598 cycles from these 284 women were used to evaluate fecundability. Both 
unadjusted and adjusted cycle-specific fecundability ratios suggested lower subsequent cycle 
fecundability in cycles in women with a short luteal phase, although this finding was not 
statistically significant. Compared to women with a normal luteal phase, those with a short 
luteal phase had 0.82 times the probability of pregnancy in the subseqeuent cycle (95% CI: 
0.67–1.47) in unadjusted analysis. After adjusting for age and smoking, the estimate did not 
change significantly (FR 0.89; 95% CI: 0.50–1.6). In a sensitivity analysis, a luteal length of 
10 days or less yielded similar results, with an unadjusted FR of 0.71 (95% CI: 0.34–1.47) 
and an adjusted FR of 0.71 (95%CI: 0.34–1.48) as compared to women with a luteal length 
of >10 days. Further, in a sensitivity analysis using luteal length as a categorical variable 
(short: 5–11 days, normal: 12–15 days, and long: 16–20 days), the odds of pregnancy were 
0.83 (95% CI: 0.46–1.51) and 1.02 (95% CI: 0.55–1.89) for women with a short or long 
luteal phase (as compared to normal), respectively.
Adjusted Kaplan-Meier curves with 95% CI demonstrated that the overall probability of 
pregnancy over 12 cycles of attempt was not different for women who had a short luteal 
length as compared to those with a normal luteal length in the first observed cycle (Figure 
3). However, women with a short luteal length in the first observed cycle did have 
significantly lower fertility for the first 6 months of attempt (p=0.02). By 12 months, there 
was no significant difference in cumulative probability of pregnancy nor were the curves 
statistically significantly different (p=0.08).
In an evaluation of recurrent short luteal phase, 126 women provided at least 3 cycles for 
analysis. Of these, 18 women had 1 short luteal length cycle (and 1 normal cycle) and 4 
women had 2 cycles with short luteal length. The prevalence of recurrent short luteal phase 
was 3%. Nineteen of 104 women without a short luteal length conceived over the course of 
the study, while 2/18 and 0/4 women with 1 or 2 short luteal cycles conceived, respectively.
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Discussion
An isolated cycle with a short luteal phase was relatively common in our cohort. Women 
with a short luteal phase were more likely to be smokers than those women without short 
luteal phase. Our findings suggest that women who had an isolated episode of short luteal 
phase may have reduced immediate fecundability. By 6 months of attempt they were less 
likely to have conceived; however, probability of infertility, lack of conception by 12 cycles 
of attempt, was not significantly higher in women with one short luteal phase. Recurrent 
cycles with a short luteal phase are uncommon in women trying to conceive.
A short luteal phase (<11 days from day of ovulation until day before menses) occurred in 
18% of all evaluable cycles. Prior cohorts evaluating menstrual cycle characteristics have not 
included populations trying to conceive. Schliep et al. reported in a prospective evaluation of 
cycle characteristics in healthy eumenorrheic women (the BioCycle study, n=259) that the 
prevalence of a cycle with a short luteal phase (defined as <10 days from the day after 
ovulation until the day before next menses) was 8.9% (11). In a further analysis looking at a 
definition of <11 days (the same criteria we have used), the prevalence of an isolated episode 
of short luteal phase was 14.9% (11). Older evaluations in young, ovulatory, reproductive 
aged women have estimated the prevalence of a short luteal phase to be around 5% (19, 20).
The prevalence of short luteal phase in our cohort is higher than previously reported in older 
studies. Our study may differ from those because of our definition of a short luteal phase. In 
our study, we defined the luteal phase as starting on the day of ovulation. In addition, 
ovulation was defined as positive only in women who obtained a positive OPK test result. 
Women were queried daily with regard to test results; this may have resulted in a higher 
response rate when compared to other methods of ascertainment. In addition, our cohort is 
comprised of women 30–44 years of age. Prior studies included younger women. There are 
data that suggest that luteal phase length may decrease with age (21, 22).
In our cohort, the only patient characteristic associated with a short luteal phase was 
smoking. In the BioCycle study, evaluating women not attempting conception, a short luteal 
phase was seen more commonly in younger, nulliparous, not sexually active patients and in 
those undertaking vigorous activity (11, 23). Smoking was not associated with luteal length; 
however, the definition of smoking was obtained differently (our study evaluated current 
smoking versus no smoking, as compared to the BioCycle study which evaluated current 
smoking versus prior smoking) (11). It is important to note that our cohort is distinctly 
different, as women in our study were all over the age of 30 years and actively trying to 
conceive. Wise et al. evaluated menstrual cycle characteristics in Danish women (n=2,653) 
attempting conception (24). Although this study did not distinguish between the menstrual 
cycle phases, women with shorter overall cycle lengths were more likely to be smokers (24). 
Presuming some of these women with shorter cycle lengths may also have a shorter luteal 
phase, this finding is consistent with our results.
Smoking has been associated with anti-estrogenic effects such as a decrease in endometrial 
cancer, earlier age of natural menopause, and increased risk for osteoporosis. (25, 26). 
Smoking may be associated with abnormal sex steroid synthesis or metabolism, although 
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studies have not been consistent in establishing the exact relationship between smoking and 
sex steroid hormones (25–30). Windham et al. prospectively evaluated reproductive aged 
women (n=403) who were smokers and found lower luteal phase progesterone levels and 
higher FSH levels at baseline (31). In addition, in vitro studies support lower progesterone 
release from luteal cells exposed to nicotine (32). Thus, it is possible that smoking interferes 
with endocrine function and sex steroids at the level of the ovary, predisposing women who 
smoke to have a luteal phase defect.
Point estimates suggest that an isolated cycle with a short luteal phase is associated with 
reduced short-term fertility. No prior studies have directly evaluated the association between 
luteal phase length and natural fertility. In the previously described prospective study of 
women trying to conceive by Wise et al., shorter cycle lengths (< 25 days) were associated 
with less than half the odds of pregnancy as compared to women with “normal” cycles of 
27–29 days in length (24). However, this study did not directly look at the length of the cycle 
phases, so an association between luteal phase length and fecundability cannot be concluded 
from this data. Baird et al. evaluated 32 women comparing menstrual cycle characteristics 
and hormonal profiles for paired conception and non-conception cycles (33). Although 
conception cycles tended to have higher luteal progesterone levels and more rapid 
luteinization, there was no difference in luteal phase length between conception and non-
conception cycles (34). Evaluating the relationship between luteal phase length and 
fecundability is admittedly difficult due to the inability to accurately define luteal length in a 
conception cycle. In an attempt to overcome this difficulty, we evaluated conception in the 
cycle immediately following one with a shortened luteal phase. Although not statistically 
significant, our point estimates are suggestive that a short luteal phase does impair short-
term fertility. Supporting this further, pregnancy rates for the first 6 months after an isolated 
cycle with a short luteal phase were decreased. However, we were unable to observe 
significant differences by 12 months. When using a theoretical sample size calculation for a 
log-rank test (method of Freedman), 962 subjects are needed to achieve 80% power with a 
type I error rate of 5%, assuming a relative risk of 0.70 for subjects with short luteal length 
in the previous cycle, and 23% of subjects being in the short luteal length class (35). Thus, 
our results of no difference in pregnancy rates at 12 months may be a Type 2 error, other 
factors contributing to fecundability, or lack of an association. This was a secondary 
analysis, so findings should be viewed as exploratory.
Recurrent short luteal phase cycles occurred in only 3% of women. This is consistent with 
findings in prior studies evaluating menstrual characteristics in healthy women not trying to 
conceive. Schliep et al reported that 3.4% of women had 2 cycles with a short luteal phase 
(11). No prior studies have evaluated the impact of a recurrent short luteal phase on 
fecundability. Although this may be an uncommon finding in women trying to conceive and 
our evaluation is limited by sample size, this preliminary data suggests that recurrent short 
luteal cycles are associated with reduced fertility. Thus, luteal phase defect, as represented 
by recurrent cycles with a short luteal phase, may represent the first stage of a spectrum in 
ovulatory dysfunction potentially impairing fertility or delaying time to pregnancy (36).
To our knowledge, ours is the first study to examine the impact of short luteal phase length 
on fecundability in a population of women with unproven reproductive potential. Our study 
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does have limitations. The cohort was composed of mostly Caucasian, well-educated, and 
older women. These findings may not be generalizable to other groups. Women choosing to 
use OPKs may be a select group. Some women were provided Clearblue Easy® OPK tests. 
However, many used other brands. Thus, these results are likely generalizable to women 
using any OPK. However, these results are not generalizable to women using other methods 
to detect ovulation such as basal body temperatures or cervical mucus monitoring. Also, 
sampling bias may have been introduced by only including women who had ovulation 
determined by use of an OPK test. Although the overall size of our cohort is large (933 
women), the number of women providing adequate information to determine luteal length 
available for analysis was lower (284). This sample size may limit our power to detect a 
change in fecundability between groups. In addition, the definition of a short luteal phase 
varies widely in the literature. Because we defined a short luteal phase using a cutoff of 11 
or fewer days (including the day of ovulation), our definition is similar to prior cohorts that 
define a short luteal phase as 10 days or less starting the day after ovulation. We also 
performed a sensitivity analysis with the exposure defined as 10 days or less (including the 
day of ovulation), without any significant change in our fecundability ratios. An additional 
sensitivity analysis evaluating luteal length as a categorical variable (in case longer cycles 
represented occult pregnancies or anovulation), yielded similar results. Further strengths of 
this study include the size of the cohort, modeling with adjustment for potential 
confounders, and the prospective nature of this study in a non-infertile population trying to 
conceive. Furthermore, recall bias was reduced by use of the daily diary to cycle 
characteristics and at home test results.
In summary, an isolated cycle with a short luteal phase is relatively common in a population 
trying to conceive; however, recurrent cycles with a short luteal phase are uncommon. Point 
estimates suggest that an isolated cycle with a short luteal length may be associated with 
reduced short-term fertility. However, future larger studies are needed to determine the long-
term impact of a short luteal phase and to evaluate the reproductive implications of recurrent 
cycles with a short luteal phase.
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Figure 1. 
Flow diagram of study enrollment
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Figure 2. 
Mean length (in days) of the luteal phase
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Figure 3. 
Adjusted Kaplan Meier curve by short luteal phase in the first observed cycle
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Table 1
Patient characteristics for the overall sample and stratified by luteal phase length
Characteristic
Overall
mean (sd) or %
(n=284)
Normal luteal
length
mean (SD) or %
(n=230)
Short luteal
length
Mean (SD) or %
(n=54
P
value
Age (years) 0.61
  <35 68% 69% 63%
  35–37 20% 19% 24%
  >37 12% 12% 13%
Race 0.86
  Non-Hispanic Caucasian 77% 77% 63%
  Other 23% 23% 24%
Education level 0.32
  Less than college degree 7% 7% 9%
  College degree 20% 19% 28%
  Some graduate work 7% 7% 7%
  Completed postgraduate 65% 68% 56%
Gravid 0.76
  No 58% 58% 55%
  Yes 42% 42% 45%
BMI (kg/m2) 0.33
  <18.5 4% 3% 4%
  18.5–24.9 63% 65% 55%
  25–29.9 19% 20% 18%
  ≥30 14% 12% 22%
Current smoking 0.04
  No 98% 99% 94%
  Yes 2% 1% 6%
Current alcohol use 0.88
  No 30% 30% 31%
  Yes 70% 70% 69%
Recent hormone
contraception2
0.54
  No 54% 55% 50%
  Yes 46% 45% 50%
Mean cycle length (days) 28.7 (3.7) 29.1 (3.5) 27.1 (4.3)
Recent hormone
contraception2
0.54
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Characteristic
Overall
mean (sd) or %
(n=284)
Normal luteal
length
mean (SD) or %
(n=230)
Short luteal
length
Mean (SD) or %
(n=54
P
value
  No 54% 55% 50%
  Yes 46% 45% 50%
1
Patient characteristics in the first observed study cycle
2Oral contraceptive pills, contraceptive patch, or contraceptive vaginal ring use in the past year
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